Tech Company Financing Transactions
RuiYi Funding Round
RuiYi, operating out of La Jolla, secured $15 million from 5AM Ventures, Apposite Capital and Aravis Ventures.
Transaction Overview
Company Name
Announced On
3/27/2014
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
5AM Ventures (Andrew Schwab)
Versant Ventures (Bradley Bolzon)
Proceeds Purpose
The financing will support the continued development of RuiYi's lead asset, RYI-008, a novel anti-IL-6 monoclonal antibody (mAb), and the discovery and development of new therapeutic mAbs targeting GPCRs, including a first-in-class mAb to cannabinoid receptor 1 (CB-1), a commercially validated but previously intractable drug target.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 Coast Blvd S. 300
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
RuiYi is focused on the discovery and development of novel biologic therapeutics that meet the medical and commercial needs for China's patients and healthcare system and that have the potential to be disruptive globally.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Grayson
Founder
Andrew Schwab
Browse more venture capital transactions:
Prev: 3/27/2014: OneRoof Energy venture capital transaction
Next: 3/27/2014: Linkdex venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs